Robert L Thomas

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Glycemic Control

Top Venues

Journal of the American Society of Nephrology : JASN

This page only lists publications with an associated author ORCID identifier.

Publications

Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes care 47 (5) (2024)
Schafer C Boeder, Robert L Thomas, Melissa J Le Roux, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial. Diabetes care (2024)
Robert L Thomas, Dena E Rifkin
Renal Reinforcements: Slowing Diabetic Kidney Disease with Multiple New Agents. Journal of the American Society of Nephrology : JASN (2024)
Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes care (2024)
Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes care 47 (5) (2024)
Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes care (2024)
Robert L Thomas, Schafer C Boeder, Vala Hamidi, Erin R Giovannetti, Justin M Gregory, Jeremy H Pettus
Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes care 47 (5) (2024)